| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Exome | 5 | 2022 | 124 | 0.930 |
Why?
|
| Mutation | 9 | 2020 | 608 | 0.740 |
Why?
|
| Humans | 27 | 2022 | 4119 | 0.690 |
Why?
|
| Genetic Association Studies | 4 | 2019 | 122 | 0.600 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2022 | 529 | 0.570 |
Why?
|
| High-Throughput Nucleotide Sequencing | 7 | 2021 | 173 | 0.550 |
Why?
|
| DNA | 1 | 2016 | 102 | 0.550 |
Why?
|
| Muscular Atrophy, Spinal | 3 | 2021 | 12 | 0.530 |
Why?
|
| Male | 16 | 2020 | 1811 | 0.480 |
Why?
|
| Phenotype | 7 | 2021 | 479 | 0.450 |
Why?
|
| Female | 14 | 2020 | 2147 | 0.410 |
Why?
|
| Arthrogryposis | 3 | 2020 | 9 | 0.380 |
Why?
|
| Pedigree | 10 | 2021 | 304 | 0.380 |
Why?
|
| Hearing Loss, Sensorineural | 2 | 2020 | 10 | 0.370 |
Why?
|
| Nephrotic Syndrome | 2 | 2020 | 8 | 0.360 |
Why?
|
| Microcephaly | 2 | 2021 | 65 | 0.350 |
Why?
|
| Nuclear Proteins | 2 | 2020 | 83 | 0.330 |
Why?
|
| MicroRNAs | 2 | 2018 | 82 | 0.300 |
Why?
|
| Child, Preschool | 8 | 2020 | 378 | 0.300 |
Why?
|
| Child | 8 | 2020 | 557 | 0.290 |
Why?
|
| Membrane Proteins | 2 | 2017 | 101 | 0.260 |
Why?
|
| Animals | 8 | 2020 | 1545 | 0.230 |
Why?
|
| Young Adult | 6 | 2020 | 345 | 0.220 |
Why?
|
| Adolescent | 6 | 2020 | 493 | 0.220 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2022 | 2 | 0.220 |
Why?
|
| Wnt Signaling Pathway | 1 | 2022 | 18 | 0.220 |
Why?
|
| Ectodermal Dysplasia | 1 | 2022 | 12 | 0.210 |
Why?
|
| Alleles | 2 | 2019 | 221 | 0.210 |
Why?
|
| Survival of Motor Neuron 1 Protein | 2 | 2018 | 4 | 0.210 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 4 | 0.200 |
Why?
|
| Adult | 6 | 2020 | 944 | 0.200 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 2021 | 6 | 0.200 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2021 | 25 | 0.200 |
Why?
|
| Exons | 3 | 2018 | 97 | 0.190 |
Why?
|
| Hypoglycemia | 1 | 2020 | 4 | 0.190 |
Why?
|
| Receptor, Insulin | 1 | 2020 | 6 | 0.190 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2020 | 13 | 0.190 |
Why?
|
| Enterocolitis | 1 | 2020 | 2 | 0.190 |
Why?
|
| Ribonucleoproteins, Small Nucleolar | 1 | 2020 | 2 | 0.190 |
Why?
|
| Computational Biology | 2 | 2015 | 164 | 0.190 |
Why?
|
| Antigens, CD | 1 | 2020 | 48 | 0.190 |
Why?
|
| Cataract | 1 | 2020 | 9 | 0.190 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2020 | 4 | 0.190 |
Why?
|
| Deafness | 1 | 2020 | 8 | 0.190 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 33 | 0.190 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 210 | 0.180 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2019 | 3 | 0.180 |
Why?
|
| Neural Plate | 1 | 2019 | 3 | 0.180 |
Why?
|
| Intellectual Disability | 1 | 2021 | 122 | 0.180 |
Why?
|
| Hyperekplexia | 1 | 2019 | 2 | 0.180 |
Why?
|
| Glycine Plasma Membrane Transport Proteins | 1 | 2019 | 3 | 0.180 |
Why?
|
| Codon | 1 | 2019 | 12 | 0.180 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2019 | 3 | 0.180 |
Why?
|
| Fetal Diseases | 1 | 2019 | 7 | 0.180 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2019 | 14 | 0.180 |
Why?
|
| Trans-Activators | 1 | 2019 | 25 | 0.180 |
Why?
|
| Optic Atrophy, Autosomal Dominant | 1 | 2019 | 2 | 0.180 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 1 | 2019 | 1 | 0.180 |
Why?
|
| Complex Regional Pain Syndromes | 1 | 2019 | 1 | 0.180 |
Why?
|
| Pain Management | 1 | 2019 | 2 | 0.180 |
Why?
|
| Chronic Pain | 1 | 2019 | 2 | 0.180 |
Why?
|
| Neuralgia | 1 | 2019 | 7 | 0.180 |
Why?
|
| Mitochondrial Proteins | 1 | 2019 | 35 | 0.180 |
Why?
|
| RNA-Binding Proteins | 1 | 2019 | 73 | 0.170 |
Why?
|
| Infant | 4 | 2020 | 267 | 0.170 |
Why?
|
| Xenopus Proteins | 1 | 2018 | 3 | 0.170 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2018 | 3 | 0.170 |
Why?
|
| Zebrafish Proteins | 1 | 2018 | 11 | 0.170 |
Why?
|
| Epilepsy, Rolandic | 1 | 2018 | 11 | 0.170 |
Why?
|
| Pathology, Molecular | 1 | 2018 | 6 | 0.170 |
Why?
|
| Neuromuscular Diseases | 1 | 2018 | 5 | 0.170 |
Why?
|
| Genetic Variation | 1 | 2019 | 189 | 0.170 |
Why?
|
| Survival of Motor Neuron 2 Protein | 1 | 2018 | 1 | 0.160 |
Why?
|
| Motor Neurons | 1 | 2018 | 5 | 0.160 |
Why?
|
| Ribonuclease III | 1 | 2018 | 9 | 0.160 |
Why?
|
| DNA-Binding Proteins | 1 | 2019 | 139 | 0.160 |
Why?
|
| Gene Deletion | 1 | 2018 | 57 | 0.160 |
Why?
|
| Autophagy | 1 | 2018 | 20 | 0.160 |
Why?
|
| Epilepsy, Generalized | 2 | 2018 | 21 | 0.160 |
Why?
|
| Sequence Deletion | 2 | 2018 | 51 | 0.160 |
Why?
|
| Sequence Analysis, DNA | 3 | 2015 | 249 | 0.160 |
Why?
|
| Embryo Loss | 1 | 2018 | 2 | 0.160 |
Why?
|
| Ectodysplasins | 1 | 2017 | 2 | 0.160 |
Why?
|
| Embryonic Development | 1 | 2018 | 16 | 0.160 |
Why?
|
| Cytokinesis | 1 | 2017 | 2 | 0.160 |
Why?
|
| Oncogene Proteins | 1 | 2017 | 13 | 0.160 |
Why?
|
| Inflammation | 1 | 2019 | 179 | 0.160 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 73 | 0.150 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2017 | 15 | 0.150 |
Why?
|
| Liver | 1 | 2017 | 61 | 0.150 |
Why?
|
| Usher Syndromes | 1 | 2017 | 1 | 0.150 |
Why?
|
| Nerve Tissue Proteins | 1 | 2018 | 74 | 0.150 |
Why?
|
| Insulin Resistance | 1 | 2017 | 64 | 0.150 |
Why?
|
| Obesity | 1 | 2017 | 86 | 0.150 |
Why?
|
| Somatosensory Disorders | 1 | 2016 | 1 | 0.150 |
Why?
|
| Scoliosis | 1 | 2016 | 2 | 0.150 |
Why?
|
| Ion Channels | 1 | 2016 | 7 | 0.150 |
Why?
|
| Mice | 4 | 2019 | 737 | 0.140 |
Why?
|
| Middle Aged | 4 | 2020 | 843 | 0.140 |
Why?
|
| Base Sequence | 1 | 2016 | 275 | 0.140 |
Why?
|
| Computing Methodologies | 1 | 2015 | 4 | 0.130 |
Why?
|
| Zebrafish | 3 | 2020 | 57 | 0.130 |
Why?
|
| Microcystins | 1 | 2014 | 1 | 0.130 |
Why?
|
| Daphnia | 1 | 2014 | 2 | 0.130 |
Why?
|
| Biotransformation | 1 | 2014 | 3 | 0.130 |
Why?
|
| Whole Genome Sequencing | 3 | 2020 | 27 | 0.130 |
Why?
|
| GABAergic Neurons | 1 | 2014 | 3 | 0.120 |
Why?
|
| Synapses | 1 | 2014 | 10 | 0.120 |
Why?
|
| Calcium Channels, L-Type | 1 | 2013 | 1 | 0.120 |
Why?
|
| Retinitis Pigmentosa | 1 | 2013 | 7 | 0.120 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2013 | 9 | 0.120 |
Why?
|
| Carrier Proteins | 1 | 2014 | 65 | 0.120 |
Why?
|
| Cells, Cultured | 3 | 2019 | 261 | 0.120 |
Why?
|
| Genome-Wide Association Study | 3 | 2022 | 417 | 0.120 |
Why?
|
| Striatonigral Degeneration | 1 | 2013 | 2 | 0.110 |
Why?
|
| NADH Dehydrogenase | 1 | 2013 | 5 | 0.110 |
Why?
|
| Genetic Linkage | 3 | 2019 | 46 | 0.110 |
Why?
|
| Deer | 1 | 2011 | 1 | 0.110 |
Why?
|
| Endogenous Retroviruses | 1 | 2011 | 1 | 0.110 |
Why?
|
| Gammaretrovirus | 1 | 2011 | 2 | 0.110 |
Why?
|
| Virus Integration | 1 | 2011 | 3 | 0.110 |
Why?
|
| Polymorphism, Genetic | 1 | 2011 | 68 | 0.100 |
Why?
|
| Gene Expression Profiling | 3 | 2019 | 345 | 0.100 |
Why?
|
| Software | 1 | 2012 | 133 | 0.090 |
Why?
|
| Protein Conformation | 2 | 2020 | 30 | 0.090 |
Why?
|
| Models, Molecular | 2 | 2020 | 50 | 0.090 |
Why?
|
| Infant, Newborn | 2 | 2020 | 119 | 0.090 |
Why?
|
| Consanguinity | 2 | 2022 | 56 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 2 | 2019 | 32 | 0.090 |
Why?
|
| DNA Copy Number Variations | 2 | 2019 | 79 | 0.080 |
Why?
|
| Protein Interaction Maps | 2 | 2018 | 19 | 0.080 |
Why?
|
| Protein Interaction Mapping | 2 | 2018 | 24 | 0.080 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 143 | 0.080 |
Why?
|
| Mice, Knockout | 2 | 2018 | 149 | 0.080 |
Why?
|
| Models, Statistical | 1 | 2008 | 46 | 0.080 |
Why?
|
| Fibroblasts | 2 | 2018 | 71 | 0.080 |
Why?
|
| Gene Regulatory Networks | 1 | 2008 | 70 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 2 | 2018 | 226 | 0.080 |
Why?
|
| Workflow | 2 | 2018 | 21 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 92 | 0.070 |
Why?
|
| Mutation, Missense | 2 | 2019 | 124 | 0.070 |
Why?
|
| Homozygote | 2 | 2018 | 117 | 0.070 |
Why?
|
| DNA Mutational Analysis | 2 | 2017 | 122 | 0.070 |
Why?
|
| RNA, Messenger | 2 | 2019 | 263 | 0.070 |
Why?
|
| Aged | 2 | 2019 | 580 | 0.070 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2022 | 5 | 0.060 |
Why?
|
| beta Catenin | 1 | 2022 | 12 | 0.050 |
Why?
|
| Limb Deformities, Congenital | 1 | 2022 | 18 | 0.050 |
Why?
|
| Syndrome | 1 | 2022 | 91 | 0.050 |
Why?
|
| Cadherin Related Proteins | 1 | 2021 | 2 | 0.050 |
Why?
|
| Cadherins | 1 | 2021 | 7 | 0.050 |
Why?
|
| Interleukin-1beta | 1 | 2021 | 10 | 0.050 |
Why?
|
| Inflammasomes | 1 | 2021 | 5 | 0.050 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2021 | 9 | 0.050 |
Why?
|
| Seizures | 1 | 2021 | 24 | 0.050 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2020 | 2 | 0.050 |
Why?
|
| Infant Mortality | 1 | 2020 | 3 | 0.050 |
Why?
|
| Infant, Premature | 1 | 2020 | 9 | 0.050 |
Why?
|
| Dehydration | 1 | 2020 | 4 | 0.050 |
Why?
|
| Molecular Sequence Annotation | 1 | 2020 | 21 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2020 | 37 | 0.050 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2020 | 4 | 0.050 |
Why?
|
| RNA, Ribosomal | 1 | 2020 | 7 | 0.050 |
Why?
|
| Keratosis | 1 | 2020 | 3 | 0.050 |
Why?
|
| Egypt | 1 | 2020 | 2 | 0.050 |
Why?
|
| Family | 1 | 2020 | 36 | 0.050 |
Why?
|
| Immunity, Innate | 1 | 2021 | 99 | 0.050 |
Why?
|
| Structure-Activity Relationship | 1 | 2019 | 8 | 0.050 |
Why?
|
| Apnea | 1 | 2019 | 2 | 0.050 |
Why?
|
| Macrophages | 1 | 2021 | 124 | 0.050 |
Why?
|
| Longevity | 1 | 2020 | 40 | 0.050 |
Why?
|
| Muscular Diseases | 1 | 2019 | 17 | 0.050 |
Why?
|
| Mitochondria | 1 | 2021 | 150 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 103 | 0.040 |
Why?
|
| Retinal Degeneration | 1 | 2019 | 9 | 0.040 |
Why?
|
| Genomics | 1 | 2021 | 143 | 0.040 |
Why?
|
| Pain, Postoperative | 1 | 2019 | 1 | 0.040 |
Why?
|
| Saliva | 1 | 2019 | 4 | 0.040 |
Why?
|
| Knee | 1 | 2019 | 3 | 0.040 |
Why?
|
| Ganglia, Spinal | 1 | 2019 | 6 | 0.040 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 29 | 0.040 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2019 | 47 | 0.040 |
Why?
|
| Cytokines | 1 | 2019 | 75 | 0.040 |
Why?
|
| Brain | 1 | 2019 | 153 | 0.040 |
Why?
|
| Xenopus laevis | 1 | 2018 | 10 | 0.040 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2018 | 24 | 0.040 |
Why?
|
| Autistic Disorder | 1 | 2018 | 12 | 0.040 |
Why?
|
| Age of Onset | 1 | 2018 | 40 | 0.040 |
Why?
|
| Point Mutation | 1 | 2018 | 36 | 0.040 |
Why?
|
| Subcellular Fractions | 1 | 2018 | 8 | 0.040 |
Why?
|
| Chromosome Deletion | 1 | 2018 | 45 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2019 | 199 | 0.040 |
Why?
|
| Biomarkers | 1 | 2019 | 188 | 0.040 |
Why?
|
| Cell Line | 1 | 2018 | 137 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2020 | 552 | 0.040 |
Why?
|
| Ectodermal Dysplasia 1, Anhidrotic | 1 | 2017 | 1 | 0.040 |
Why?
|
| Mice, Obese | 1 | 2017 | 4 | 0.040 |
Why?
|
| Mice, Inbred CBA | 1 | 2017 | 6 | 0.040 |
Why?
|
| Caspase 7 | 1 | 2017 | 1 | 0.040 |
Why?
|
| Tubulin | 1 | 2017 | 6 | 0.040 |
Why?
|
| Family Health | 1 | 2017 | 24 | 0.040 |
Why?
|
| Pregnancy | 1 | 2018 | 113 | 0.040 |
Why?
|
| C9orf72 Protein | 1 | 2017 | 1 | 0.040 |
Why?
|
| Cell Movement | 1 | 2017 | 45 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2017 | 50 | 0.040 |
Why?
|
| Mutation Rate | 1 | 2017 | 16 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 111 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2017 | 45 | 0.040 |
Why?
|
| Saudi Arabia | 1 | 2017 | 4 | 0.040 |
Why?
|
| Databases, Genetic | 1 | 2017 | 62 | 0.040 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2016 | 3 | 0.040 |
Why?
|
| Muscle Weakness | 1 | 2016 | 5 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2017 | 322 | 0.040 |
Why?
|
| Genotype | 1 | 2017 | 320 | 0.040 |
Why?
|
| Ecosystem | 1 | 2014 | 31 | 0.030 |
Why?
|
| Cyanobacteria | 1 | 2014 | 11 | 0.030 |
Why?
|
| Ophthalmoscopes | 1 | 2013 | 1 | 0.030 |
Why?
|
| Tomography, Optical Coherence | 1 | 2013 | 1 | 0.030 |
Why?
|
| Risk Factors | 1 | 2014 | 265 | 0.030 |
Why?
|
| Electron Transport Complex I | 1 | 2013 | 18 | 0.030 |
Why?
|
| Siblings | 1 | 2013 | 28 | 0.030 |
Why?
|
| Transcriptome | 1 | 2014 | 201 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2011 | 17 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 2011 | 301 | 0.030 |
Why?
|
| Genome | 1 | 2011 | 77 | 0.020 |
Why?
|
| Phylogeny | 1 | 2011 | 208 | 0.020 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2008 | 11 | 0.020 |
Why?
|
| DNA Repair Enzymes | 1 | 2008 | 8 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2008 | 48 | 0.020 |
Why?
|
| DNA Repair | 1 | 2008 | 60 | 0.020 |
Why?
|
